Bonnie Bucqueroux teaches at Michigan State University's School of Journalism. A National Magazine Award winner, Bucqueroux built her first website in 1996. She is credited with having the first campaign blog of any candidate running for federal office when she ran for Congress as the Green Party candidate for District 8 in 2000. She and Susan Masten were also recently named co-presidents of Lansing Area NOW.

One response to “VIDEO: The Story of Steve and Maria”

  1. BROUGHT TO YOU BY NJWEEDMAN.COM — VOTE LIBERTARIAN —
    http://www.njweedman.com/challenge.pdf
    10 | P a g e MOTION TO DISMISS & BRIEF IN SUPPORT OF MOTION
    “The hypocrisy-Federal Gov’t Recognizes medical marijuana with Patent”
    The US Government officially classifies marijuana as Schedule 1 defined as having, “No medicinal value and highly addictive” yet the Federal Government has issued a patent for using cannabinoids as an antioxidant and neuro-protectant to the DEA. The U.S. government which includes the DEA has medical marijuana Patent #6630507. So once again on the one hand, United States federal government officials have consistently denied that marijuana has any medical benefits. On the other, the government actually holds patents for the medical use of the plant. This fact again disqualifies the State of New Jersey’s classification of “marijuana” as a schedule 1 drug for N.J.S.A. 24:21-5 clearly defines schedule 1 substances as ….”has no accepted medical use in treatment in the United States,) US Patent 6630507 titled “Cannabinoids as antioxidants and neuro-protectant” is assigned to The government of The United States of America!!!
    The Federal patent says “useful”:
    “Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuro-protectant, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease and HIV dementia.”
    The patent #6630507 was obtained in October of 2003.

Leave a Reply